Molecular and Cellular Pathology
British Journal of Cancer (2004) 91, 1566–1570. doi:10.1038/sj.bjc.6602138 www.bjcancer.com
Published online 31 August 2004
Zinc-finger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients
X-Y Dong1,2, X-A Yang1,2, Y-D Wang1 and W-F Chen1
1Department of Immunology, School of Basic Medical Science, Peking University Health Science Center, 38 Xue Yuan Road, Beijing 100083, China
Correspondence: Dr W-F Chen, E-mail: wfchen@public.bta.net.cn
2The first two authors contribute equally to this work
Received 16 February 2004; Revised 7 July 2004; Accepted 16 July 2004; Published online 31 August 2004.
Abstract
ZNF165 is a zinc-finger protein gene that was identified from human adult testis. Analysis of the origins of publicly available expressed sequence tags as presented in Unigene and SAGE databases revealed that ZNF165 mRNA was expressed in tumours of different tissues. RT–PCR, real-time PCR and Northern blotting analysis confirmed that ZNF165 mRNA was expressed in the hepatocellular carcinoma, gastric cancer, colon cancer and non-small-cell lung carcinoma. The nucleotide sequence of ZNF165 expressed in tumours is identical to that expressed in the testis. Humoral responses of hepatocellular carcinoma (HCC) patients against ZNF165 protein were determined by Western blotting using the recombinant ZNF165 protein. Antibodies against ZNF165 protein were detected in approximately 5% (four of 82) of the sera from HCC patients. These results suggest that ZNF165, a member of the ZNF family, is a novel CT antigen capable of eliciting humoral immune response and be involved in tumour biology.
Keywords:
zinc-finger protein, transcription factor, cancer-testis antigen, serum antibody, tumorigenesis
